Skip to content
MARKETS / NASDAQ / AIXC
NASDAQ · FINANCE SERVICES · SMALL CAP

AIxCrypto Holdings, Inc. AIXC

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$-17.0M
In brief

What this company does

The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (“RWA”) and the deployment of Embodied Artificial Intelligence (“EAI”) in commercial environments. In September 2025, the Company closed a $41 million PIPE financing and subsequently , in November 2025, rebranded from Qualigen Therapeutics to AIxCrypto Holdings, Inc. (Nasdaq: AIXC). In February 2026, the Company’s board determined to concentrate on the RWA + Embodied AI (EAI) ecosystem. AIxC develops and operates software infrastructure for the digitization of traditional assets onto distributed ledger networks.

Written from the business description in AIxCrypto Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 30 March 2026. Every sentence was checked against that document before publication.

Growth
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2022 · Revenue 5.0 · Net income -18.6
2M4M-8M-16M2014201620182020202220242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
Operating margin Net margin
FY2022 · Operating -296.2% · Net -422.1%
-200%-400%2014201620182020202220242025
ROE
FY2025 · ROE -110.8%
-5000%2014201620182020202220242025

Each USD of equity lost 111 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2022 · FCF -13.4
-8M2014201620182020202220242025
Net buybacks $ Dividends $
FY2015 · Dividends — · Net buybacks -999820.0
-400000-8000002015

Total assetsUSD 31.3M
EquityUSD 28.0M
CashUSD 19.3M
Gross debtUSD 4.4M
Net debtUSD -14.9M
Current ratio9.30×

The company holds more cash than debt.

The 12-year record
12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182017201620152014
Revenue $B···0.00.00.0······
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B··−0.0−0.0−0.0·−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.00.00.0·······
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B···−0.0−0.0·−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−8.11−17.55−132.25·−0.61−1.17−1.06−3.66−4.95−2.04−3.11−6.79
Dividend / sh $············
Payout %············
ROE %−110.8−2175.3−522.9−156.6−102.7−210.6−193.3−114.3−64.8−195.4−9252.6·
Shares out B0.010.000.000.000.000.030.020.010.000.010.010.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 2 failures · 3 divergences in 49 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 3 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 46 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente2 failures3 divergent
ActivityFinance Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2014

Share this section

Download image